BLACR
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
BLACR
Delisted
BLACR was delisted on the 14th of February, 2025.
28 hedge funds and large institutions have $550K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CAC
1
Cowen and Company
New York
|
$35.3K |
| 2 |
FTUS
2
Flow Traders U.S.
New York
|
$2K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BI
26
Bulldog Investors
Saddle Brook,
New Jersey
| $1.61K | -$436 | -4,180 | -21% |
|
|
WC
27
Wealthspring Capital
West Harrison,
New York
| $1.34K | – | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $10 | – | – | – |
|
|
EAM
29
Exos Asset Management
New York
| – | -$18.1K | -178,900 | Closed |
|
30
UBS Group
Zurich,
Switzerland
| – | -$2 | -22 | Closed |
|